HI
ACAD icon

Harbour Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Harbour Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,110
Closed -$26.6K – 2996
2023
Q2 		$26.6K Hold
1,110
– – ﹤0.01% 1645
2023
Q1 		$20.9K Hold
1,110
– – ﹤0.01% 1725
2022
Q4 		$17.7K Hold
1,110
– – ﹤0.01% 1733
2022
Q3 		$16K Hold
1,110
– – ﹤0.01% 1737
2022
Q2 		$16K Buy
+1,110
New +$20.7K ﹤0.01% 1737
2021
Q4 		$38K Sell
1,610
-200
-11% -$4.02K ﹤0.01% 1375
2021
Q3 		$30K Sell
1,810
-315
-15% -$6.07K ﹤0.01% 2062
2021
Q2 		$52K Buy
2,125
+2,025
+2,025% +$45.7K ﹤0.01% 1791
2021
Q1 		$3K Buy
+100
New +$4.4K ﹤0.01% 3050

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return